These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 39218074)

  • 1. PDE6A-Associated Retinitis Pigmentosa, Clinical Characteristics, Genetics, and Natural History.
    Hashem SA; Georgiou M; Wright G; Fujinami-Yokokawa Y; Laich Y; Daich Varela M; de Guimaraes TAC; Mahroo OA; Webster AR; Fujinami K; Michaelides M
    Ophthalmol Retina; 2024 Aug; ():. PubMed ID: 39218074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of 0.19-mg Fluocinolone Acetonide Implant in Postoperative Cystoid Macular Edema after Pars Plana Vitrectomy: The ILUvien in Postoperative CYstoid Macular eDema Study.
    Motloch K; Soler V; Delyfer MN; Vasseur V; Wolff B; Issa M; Dot C; Massé H; Weber M; Comet A; Hitzl W; Matonti F; Creuzot-Garcher C; Tadayoni R; Kodjikian L; Couturier A
    Ophthalmol Retina; 2024 Dec; 8(12):1181-1191. PubMed ID: 39004282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal and Vitreous Changes Associated with Spontaneous Improvement in Myopic Macular Schisis.
    Goudot M; Couturier A; Beaumont W; Gaudric A; Tadayoni R; Philippakis E
    Ophthalmol Retina; 2024 Dec; 8(12):1192-1199. PubMed ID: 38950656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.
    Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF
    Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.
    Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L
    Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal Characteristics of Female Choroideremia Carriers: Multimodal Imaging, Microperimetry, and Genetics.
    Gocuk SA; Edwards TL; Jolly JK; McGuinness MB; MacLaren RE; Chen FK; Taylor LJ; McLaren TL; Lamey TM; Thompson JA; Ayton LN
    Ophthalmol Retina; 2024 Dec; 8(12):1200-1210. PubMed ID: 38936773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-VEGF drugs compared with laser photocoagulation for the treatment of diabetic retinopathy: a systematic review and meta-analysis.
    Simmonds M; Llewellyn A; Walker R; Fulbright H; Walton M; Hodgson R; Bojke L; Stewart L; Dias S; Rush T; Lawrenson JG; Peto T; Steel D
    Health Technol Assess; 2024 Dec; ():1-71. PubMed ID: 39673354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laser-assisted cataract surgery versus standard ultrasound phacoemulsification cataract surgery.
    Narayan A; Evans JR; O'Brart D; Bunce C; Gore DM; Day AC
    Cochrane Database Syst Rev; 2023 Jun; 6(6):CD010735. PubMed ID: 37369549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macular Capillary Nonperfusion in Eyes With Stable Laser-Treated Proliferative Diabetic Retinopathy.
    Thottarath S; Tsai WS; Gurudas S; Pearce E; Cheung CMG; Yamaguchi TCN; Sivaprasad S
    JAMA Ophthalmol; 2024 Nov; ():. PubMed ID: 39602145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ReCLAIM-2: A Randomized Phase II Clinical Trial Evaluating Elamipretide in Age-related Macular Degeneration, Geographic Atrophy Growth, Visual Function, and Ellipsoid Zone Preservation.
    Ehlers JP; Hu A; Boyer D; Cousins SW; Waheed NK; Rosenfeld PJ; Brown D; Kaiser PK; Abbruscato A; Gao G; Heier J;
    Ophthalmol Sci; 2025; 5(1):100628. PubMed ID: 39605874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraretinal Retinal Pigment Epithelium Cells in Age-Related Macular Degeneration.
    Panda-Jonas S; Jonas RA; Xu J; Wang YX; Jonas JB
    Ophthalmol Sci; 2025; 5(2):100626. PubMed ID: 39639888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Factors for Meeting Criteria for Switching from Bevacizumab to Aflibercept When Treating Eyes with Diabetic Macular Edema and Visual Acuity of < 20/40.
    Jhaveri CD; Liu D; Maguire MG; Glassman AR; Grigorian RA; Jampol LM; Kingsley RM; MacCumber MW; Martin DF; Maturi RK; Velez G; Sun JK;
    Ophthalmology; 2024 Aug; 131(8):967-974. PubMed ID: 38336282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of pregnancy on disease progression of retinitis pigmentosa.
    Varela MD; Rashid M; Lopes A; Michaelides M
    Am J Ophthalmol; 2024 Nov; ():. PubMed ID: 39615819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What Are the Functional, Radiographic, and Survivorship Outcomes of a Modified Cup-cage Technique for Pelvic Discontinuity?
    Mu W; Xu B; Wahafu T; Wang F; Guo W; Zou C; Cao L
    Clin Orthop Relat Res; 2024 Dec; 482(12):2149-2160. PubMed ID: 38991223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Face-down positioning or posturing after pars plana vitrectomy for macula-involving rhegmatogenous retinal detachments.
    Fung TH; Yim TW; Lois N; Wright DM; Liu SH; Williamson T
    Cochrane Database Syst Rev; 2024 Mar; 3(3):CD015514. PubMed ID: 38488250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collagenase injection versus limited fasciectomy surgery to treat Dupuytren's contracture in adult patients in the UK: DISC, a non-inferiority RCT and economic evaluation.
    Dias J; Tharmanathan P; Arundel C; Welch C; Wu Q; Leighton P; Armaou M; Corbacho B; Johnson N; James S; Cooke J; Bainbridge C; Craigen M; Warwick D; Brady S; Flett L; Jones J; Knowlson C; Watson M; Keding A; Hewitt C; Torgerson D
    Health Technol Assess; 2024 Dec; 28(78):1-262. PubMed ID: 39644138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supplemental Intravitreal Ranibizumab Injections in Eyes Treated with the Port Delivery System with Ranibizumab in the Archway Trial.
    Nielsen JS; Chang A; Holekamp NM; Cavichini-Cordeiro M; Lin SL; Heinrich D; Maass KF; Menezes A; Singh N; Pieramici DJ
    Ophthalmol Retina; 2024 Dec; 8(12):1127-1139. PubMed ID: 38914294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vision Loss Reduction with Avacincaptad Pegol for Geographic Atrophy: A 12-Month Post Hoc Analysis of the GATHER1 and GATHER2 Trials.
    Danzig CJ; Khanani AM; Kaiser PK; Chang MA; Kovach JL; Lally DR; Rachitskaya A; Sheth VS; Vajzovic L; Clark J; Tang J; Zhu L; Desai D; Chakravarthy U
    Ophthalmol Retina; 2024 Nov; 8(11):1052-1060. PubMed ID: 38719191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinal Fluid and Thickness Fluctuations in Archway Trial for Port Delivery System with Ranibizumab versus Monthly Ranibizumab Injections.
    Sheth VS; Holekamp NM; Khanani AM; Rachitskaya A; Blotner S; Gune S; Heinrich D; Maass KF; Chakravarthy U
    Ophthalmol Retina; 2024 Oct; ():. PubMed ID: 39447871
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.